Adjuvant antiplatelet strategies in coronary thrombolysis.
- 1 March 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 83 (3), 1115-1117
- https://doi.org/10.1161/01.cir.83.3.1115
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparationJournal of the American College of Cardiology, 1990
- Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human plateletsBiochemistry, 1989
- Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.Circulation, 1989
- Effect of thromboxane synthase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosisThrombosis Research, 1988
- EFFECTS OF INTERMITTENT TREATMENT WITH ASPIRIN ON THROMBOXANE AND PROSTACYCLIN FORMATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.Proceedings of the National Academy of Sciences, 1988
- Anticoagulants After ThrombolysisPublished by Springer Nature ,1988
- Tissue plasminogen activator promotes platelet disaggregation in plasma.JCI Insight, 1987
- Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.JCI Insight, 1986
- Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chainBiochemistry, 1984